← All trials
NCT01261234
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2010
- Primary completion
- Mar 1, 2014
- Completion date
- Mar 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 900
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Kobe UniversityLead sponsor
- Kobe UniversityOverall official - principal investigator
- Chiba UniversityCollaborator
- Nagoya UniversityCollaborator
- Mie UniversityCollaborator
- Wakayama Medical UniversityCollaborator
- Kyoto UniversityCollaborator
- Osaka UniversityCollaborator
- Kobe UniversityCollaborator
- Foundation for Biomedical Research and InnovationCollaborator
- Okayama UniversityCollaborator
- Fukuoka UniversityCollaborator
- Yamaguchi UniversityCollaborator
- Kobe UniversityReponsible party - principal investigator
- University of NagasakiCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.